Tirzepatide Online — The Most Effective GLP-1 Available.
Clinical trials show up to 22% body weight reduction. REMEVi connects you with a licensed physician and ships compounded tirzepatide directly to your door. From $249/month* on a 24-week plan (or $289/month monthly), all-inclusive.
The Science
How tirzepatide works
Tirzepatide is a dual GIP/GLP-1 receptor agonist that mimics two natural hormones to regulate appetite, metabolism, and blood sugar.
Reduces Appetite
Signals the brain to eat less and feel full longer.
Slows Gastric Emptying
Slows food movement through the digestive system.
Improves Blood Sugar
Regulates glucose and reduces cravings via GIP + GLP-1.
Dual-Action Mechanism
Activates two receptors for greater weight loss than GLP-1 alone.
Treatment Plan
Tirzepatide dosing protocol
Physician-supervised dose escalation every 4 weeks to maximize results and minimize side effects.
Dose Escalation
Weeks 1–4
2.5 mg
Starter dose weekly
Weeks 5–8
5 mg
First therapeutic dose
Weeks 9–12
7.5 mg
Increased every 4 weeks
Weeks 13–24
10–15 mg
Titrate to maintenance
Delivery & Support
Injection Method
Subcutaneous (under the skin)
Frequency
Once per week
Physician Check-ins
Monthly dose adjustments
Timeline
Full 24-week program
What to Expect
Tirzepatide results timeline
Weight loss milestones and what patients typically experience at each phase.
Weeks 1–4
Appetite Suppression
Noticeable decrease in hunger and food cravings begins.
Weeks 5–12
5–10% Loss
Body weight reduction of 5–10% is common at this phase.
Weeks 13–24
Up to 15–22%
Total body weight loss in clinical trials (SURMOUNT-1).
Ongoing
Maintenance
Maintenance dosing available to preserve results long-term.
Results vary based on adherence, diet, exercise, and individual metabolism. Your REMEVi physician will monitor your progress and adjust dosing as needed.
All-Inclusive
Everything in one price. No surprises.
Unlike Hims, Ro, and Medvi — there are no hidden lab fees or add-on charges.
Licensed US Physician
Prescription from a board-certified US physician who reviews your full health history.
503B Compounded Tirzepatide
Compounded tirzepatide from a 503B-accredited pharmacy under strict quality control.
Free Discreet Shipping
Medication shipped directly to your door in unmarked packaging. Free every month.
Bilingual Support
Care team available in English and Spanish with a 2-hour response SLA.
Monthly Check-ins
Regular check-ins with your care team to adjust dosage and monitor your progress.
LegitScript Certified
REMEVi is a LegitScript-certified telehealth platform you can trust.
Pricing
Tirzepatide pricing
Pay monthly or commit for significant savings. All-inclusive — medication, physician review, coaching, and shipping.
- ✓Everything in Semaglutide
- ✓Dual GIP/GLP-1 mechanism
- ✓22.5% avg weight loss
- ✓Faster results timeline
Named out loud, answered in full.
REMEVi's semaglutide is compounded by an FDA-registered 503B outsourcing facility — the same regulatory tier hospitals use. Same active ingredient as brand-name Wegovy, prepared to USP <797> sterility standards, prescribed by a licensed provider in your state.
FAQ
Tirzepatide questions answered
Tirzepatide is a dual GIP/GLP-1 receptor agonist medication approved for weight management. It works by reducing appetite and improving blood sugar regulation.
REMEVi uses compounded tirzepatide from a 503B-accredited pharmacy — clinically equivalent active ingredient at a fraction of the brand-name cost.
Starting from $249/month on our 24-week commitment plan, or $289/month on a monthly plan. No hidden fees.
Clinical trials (SURMOUNT-1) showed tirzepatide at the highest dose produced up to 22% body weight loss, generally outperforming semaglutide trials. Individual results vary.
Most patients notice appetite changes in the first 2–4 weeks. Meaningful weight loss typically becomes visible by weeks 8–12.
Yes. Your REMEVi physician can evaluate a transition during your consultation.
Ready to Start?
5-minute intake. Physician review within 24 hours. Medication shipped free.
Start Free Consultation — from $249/mo* →